BioNTech SE
BNTX- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001776985
In the last 90 days, BioNTech SE insiders filed 0 open-market purchases and 8 sales; 283 institutions reported holding it in 13F filings for Q2 2026, worth $4.82B in total; ARK Invest is the only superinvestor holding it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by BioNTech SE insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 8 filings
- 1 insider, $51.2M in total
- Insiders trading
- 1
- Net value
- −$51.2M
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for BioNTech SE, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Sahin Ugur | Chief Executive Officer | 341,209 | Sep 24, 2026 | 8 |
| Poetting Sierk | Chief Operating Officer | 399,387Indirect | May 13, 2026 | 2 |
| Hanekamp Annemarie | Chief Commercial Officer | – | May 13, 2026 | 1 |
| Ryan James Timothy Patrick | See remarks. | – | May 13, 2026 | 1 |
| Jimenez Kylie | Chief People Officer | – | May 13, 2026 | 1 |
| Zapata Gomez Ramon | Chief Financial Officer | – | May 13, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 24, 2026 (view filing)4:26 PM ET | Sep 23-24 | 1 day | Sahin UgurChief Executive Officer | SSale | −69.0K | $99.17 | −$6.84M | −16.8%341.2K after | 2 lots10b5-1 |
| Sep 22, 2026 (view filing)5:04 PM ET | Sep 21-22 | 1 day | Sahin UgurChief Executive Officer | SSale | −79.0K | $99.50 | −$7.86M | −16.1%410.2K after | 2 lots10b5-1 |
| Sep 18, 2026 (view filing)4:41 PM ET | Sep 17-18 | 1 day | Sahin UgurChief Executive Officer | SSale | −64.0K | $97.49 | −$6.24M | −11.6%489.2K after | 2 lots10b5-1 |
| Sep 16, 2026 (view filing)4:46 PM ET | Sep 15-16 | 1 day | Sahin UgurChief Executive Officer | SSale | −49.0K | $96.37 | −$4.72M | −8.1%553.2K after | 2 lots10b5-1 |
| Sep 14, 2026 (view filing)4:50 PM ET | Sep 11-14 | 3 days | Sahin UgurChief Executive Officer | SSale | −86.0K | $98.13 | −$8.44M | −12.5%602.2K after | 2 lots10b5-1 |
| Sep 11, 2026 (view filing)5:18 PM ET | Sep 10 | 1 day | Sahin UgurChief Executive Officer | SSale | −20.5K | $96.31 | −$1.97M | −2.9%688.2K after | 10b5-1 |
| Sep 9, 2026 (view filing)5:29 PM ET | Sep 8-9 | 1 day | Sahin UgurChief Executive Officer | SSale | −73.0K | $98.50 | −$7.19M | −9.3%708.7K after | 2 lots10b5-1 |
| Sep 8, 2026 (view filing)4:10 PM ET | Sep 3-4 | 5 days | Sahin UgurChief Executive Officer | SSale | −76.5K | $103.12 | −$7.89M | −8.9%781.7K after | 2 lots10b5-1 |
| Apr 23, 2026 (view filing) | Apr 22 | 1 day | Poetting SierkChief Operating Officer | SSale | −50.0K | $110.56 | −$5.53M | −11.1%399.4K after | 10b5-1 |